Wells Fargo’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-63
Closed -$5K 7265
2021
Q3
$5K Sell
63
-3
-5% -$238 ﹤0.01% 6364
2021
Q2
$5K Sell
66
-2
-3% -$164 ﹤0.01% 6326
2021
Q1
$5K Sell
68
-1
-1% -$78 ﹤0.01% 6488
2020
Q4
$1K Sell
69
-2
-3% -$165 ﹤0.01% 6326
2020
Q3
$2K Sell
71
-3
-4% -$229 ﹤0.01% 6125
2020
Q2
$1K Hold
74
﹤0.01% 6156
2020
Q1
$35K Hold
74
﹤0.01% 5454
2019
Q4
$5K Sell
74
-2
-3% -$136 ﹤0.01% 6031
2019
Q3
$2K Hold
76
﹤0.01% 6183
2019
Q2
$7K Buy
+76
New +$5.39K ﹤0.01% 5976
2019
Q1
Sell
-76
Closed -$15K 6075
2018
Q4
$15K Sell
76
-130,000
-100% -$8.13M ﹤0.01% 5834
2018
Q3
$44K Buy
130,076
+130,000
+171,053% +$8.66M ﹤0.01% 5629
2018
Q2
$13K Buy
+76
New +$4.97K ﹤0.01% 5906
2017
Q4
Sell
-22,300
Closed -$22K 6357
2017
Q3
$22K Sell
22,300
-23,700
-52% -$1.71M ﹤0.01% 5683
2017
Q2
$95K Buy
+46,000
New +$3.42M ﹤0.01% 5188
2014
Q1
Sell
-1,900
Closed -$2K 5883
2013
Q4
$2K Buy
+1,900
New +$122K ﹤0.01% 5530

Other funds holding CL

Wells Fargo's CL Position: Q1 2026 in Review

Wells Fargo increased its Colgate-Palmolive (CL) stake by 4% in Q1 2026, buying an estimated $14.1M and bringing the position to 4,125,666 shares worth $352M. The position accounts for 0.07% of the portfolio, ranked #255.

Wells Fargo first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $816M in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Wells Fargo held 4,125,666 shares of Colgate-Palmolive worth $352M as of Q1 2026.
  • Wells Fargo bought 158,255 Colgate-Palmolive shares in Q1 2026, an estimated $14.1M.
  • Colgate-Palmolive made up 0.07% of Wells Fargo's portfolio in Q1 2026, its #255 holding.
  • Wells Fargo first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Colgate-Palmolive position peaked at $816M in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.